| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
In the medical imaging industry, the main function is to help doctors diagnose diseases more accurately and quickly. Deep learning algorithms can analyze a huge amount of medical image data in real time. And help identify minor abnormalities that may be overlooked with the human eye Which reduces the risk of human error and leads to better results for patients |
Artificial Intelligence (AI) |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
Because the important role of AI is to improve diagnostic accuracy by providing additional perspectives or identifying points that may be overlooked by humans. |
Artificial intelligence (AI) in radiology serves as a second medical opinion, helping to support the diagnosis of radiologists in detecting abnormalities or diseases. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
AI literacy or AI intelligence refers to a person's ability to understand and use artificial intelligence technology critically and effectively. |
Basic functionality of AI, application of AI in various contexts, evaluation of AI performance and taking into account the ethics of using AI is not just specialized skills such as machine repair, legal knowledge or financial management. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
A factor that has not been identified as influencing the acceptance of AI among health professionals is the color of the AI machine, which is not related to other abstract factors such as understanding of the system or trust. |
Education |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Social influence plays an important role in the adoption of AI in healthcare. |
Education |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
One of the most recognizable concerns is the possibility that AI will replace human health professionals. This concern is often due to fear of unemployment or the feeling that health care may lose "humanity". |
The context of using artificial intelligence (AI) in healthcare settings |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
The human-centered design ensures that AI systems meet the needs, workflows, and expectations of medical professionals, which reduces resistance and increases acceptance. |
This concept is based on the principles of human-computer interaction design (Human-Computer Interaction - HCI) and ergonomics (Ergonomics), which emphasizes usability, reliability and integration with real work processes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
In Line With The Concept That The Adoption Of New Technologies Such As AI In Work It Is Necessary To Consider The Benefits That Users Will Receive (Value Proposition) And The Ease Of Use In Existing Workflows (Integration With Workflows). These Factors Are An Important Part Of Assessing The Actual Usability Of The System. |
The related theory is the Technology Acceptance Model (TAM), which states that the acceptance of technology depends on the perception of usefulness (Perceived usefulness) and the perception of ease of use (Perceived ease of use). "The value offered" is consistent with the perception of benefits, while "Integration into the work process" is consistent with the perception of ease of use. Which is the basic principle in the study of the acceptance factors of the use of information systems |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethics has a significant impact on the acceptance of Al among medical personnel. Because AL must be consistent with professional practices and core values such as patient independence, fairness and non-harm. |
The principles that support this answer are the theory of technology acceptance (Technology Acceptance Model - TAM) and medical ethics principles (Medical Ethics Principles), which point out that recognizing the suitability and consistency of technology with professional values and norms is an important factor in the application and acceptance. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
This research explores the determinants affecting academic researchers’ acceptance of AI writing tools using the Theory of Reasoned Action (TRA). |
This research explores the determinants affecting academic researchers’ acceptance of AI writing tools using the Theory of Reasoned Action (TRA). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
The main purpose of stem cell transplantation is to replace dead cells, which are the direct cause of the disease. |
This principle is based on the pathophysiology of Parkinson's disease that states that dopamine deficiency is the main cause of symptoms. Transplant therapy therefore aims to restore dopamine levels to normal by increasing the number of cells that produce dopamine. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Many animals have been used in scientific research to test drugs and medical products, including laboratory mice, rabbits, and monkeys. In the context of medical research, especially related to the nervous system or cell transplantation, the use of mammals with genetic and physiological similarities close to humans, such as monkeys, is often very important for safety and efficacy testing before human trials. |
The basic principle of biomedical research is animal testing (preclinical trials) before clinical trials in humans (clinical trials) to ensure safety and initial effectiveness. Especially in the field of stem cell transplantation (stem cell transplantation) for neurological diseases such as Parkinson's disease (PD), it is necessary to use the most suitable animal model, such as monkeys, to accurately simulate disease conditions and evaluate treatment results. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
3 months |
|
However, in general, long-term toxicity studies (chronic toxicity studies) in laboratory rats usually have a period of 3 months (90 days) for experiments in rodents (rodents) to assess long-term health effects. |
Based on a general principle in science, the 3 Months option is the most likely answer in the context of preclinical toxicology studies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
STEM-PD is a clinical trial in phase I/IIa, which is a combination of phase I (emphasis on safety and appropriate dosage determination) and phase IIa (emphasis on initial efficacy testing). Phase I trials are usually the first test in humans to assess safety and side effects, while phase II focuses on the effectiveness of the drug for a specific disease or symptom. |
The process of developing a new drug must pass several clinical tests (phase I, II, III, IV) to ensure safety and effectiveness before actually using. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
STEM-PD products are manufactured under conditions that comply with GMP (Good Manufacturing Practice) standards, which are necessary requirements for the production of medical products to ensure quality, safety and efficiency. |
Production of medical products to ensure quality, safety and efficiency. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
According to safety studies in experimental rats, STEM-PD cells were found to be safe. By staying within the transplant site for a long time without signs of spreading to other parts of the body, no signs of toxicity were found and no tumor formation. |
An important principle in testing the safety of medical products is to observe the occurrence of side effects (adverse effects) or tumor formation (tumor formation) in experimental animals. If these are not found It will be considered that the product is initially safe for further experiments. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The question asks for a key finding from an efficacy study of STEM-PD in rats. The correct option states that the transplanted cells reversed motor deficits, which is a positive outcome expected from a successful efficacy study aimed at treating a condition like Parkinson's disease (PD). The other options suggest negative or failed outcomes, which would be unlikely to be the key finding of a successful study. |
The other options suggest negative or failed outcomes, which would be unlikely to be the key finding of a successful study. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
GIRK2 and ALDH1A1 are specific indicators used to evaluate the purity of stem cell-derived dopamine neurons (STEM-PD). |
Research related to the treatment of Parkinson's disease using stem cells often uses a method of examining cell purity with these markers before clinical trials. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
FGFs are known to play pivotal roles in numerous cellular processes related to the development and repair of tissues, including the brain. |
Growth factors like FGF8b and SHH act as signaling molecules that regulate cell growth, proliferation, and differentiation. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
The question asks about a key outcome measured in preclinical trials for efficacy in rats. In many preclinical studies involving rats, particularly those related to neurological conditions, spinal cord injuries, or stroke, the recovery of motor function is a critical endpoint to evaluate the effectiveness of a treatment or intervention. The options related to cognitive abilities or anxiety are less likely to be the key efficacy measure in typical preclinical models compared to a functional outcome like motor recovery. |
Education |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|